What You Should Know:
- Clinical trials technology company Medidata has
acquired the digital biomarker business of MC10.
- MC10’s offerings will bring novel clinical analytics
and biosensor capabilities to Medidata’s existing technology solutions,
enhancing Medidata’s capabilities to integrate data from wearable sensors –
including clinical grade metrics – in clinical trials.
- With this acquisition, Medidata’s integrated offering
will help provide life sciences companies and device
Read More
MC10
LabCorp Forms Strategic Partnership with MC10 to Support Adoption of BioStamp Sensor
Global life sciences company LabCorp has formed a strategic collaboration with MC10, a digital health startup developing wearable sensor systems for seamless healthcare data collection. As part of the strategic partnership, LabCorp has also made an equity investment into MC10 to support adoption of it’s proprietary technology for use by LabCorp’s Covance Drug Development business in clinical trials and research studies, with the potential to be adapted over time for use in patient testing and
Read More
